RBCC Poised To Gain Share Of $142 Billion Market
June 05 2013 - 05:00AM
Business Wire
With innovative drug therapies gaining in popularity, Rainbow
BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp.
(OTCBB: RBCC), continues its partnering talks with a transdermal
patch company as it readies to take a share of the booming $142
billion U.S. drug delivery market.
Industry insiders forecast the transdermal delivery market could
rise as high as $31.5 billion by 2015 and will only continue to
grow as it is used for many treatments, including nicotine
addiction and Parkinson’s disease.
Transdermal patches have gained in popularity in recent years
and offer major advantages to patients. They are easy to use,
dispense the medicine gradually and to a designated area, last
longer and reduce side effects, among other gains for patients.
“Personalized medicine is the future,” RBCC CEO Patrick Brown
said. “This is an incredible breakthrough for any patient who
doesn’t want to take pills or is afraid of needles. The transdermal
patch empowers the patient to medicate on their schedule. It is
perfect for our growing elderly population.”
RBCC has formed a biotech subsidiary, Rainbow BioSciences, to
market and develop new medical and research technology innovations
to compete alongside companies such as Bristol Myers Squibb Co.
(NYSE: BMY), Biogen Idec Inc. (NASDAQ: BIIB), Abbot Laboratories
(NYSE: ABT) and Amgen, Inc. (NASDAQ: AMGN).
About Rainbow BioSciences
Rainbow BioSciences, LLC, is a wholly owned subsidiary of
Rainbow Coral Corp. (OTCBB: RBCC). The Company continually seeks
out new partnerships with biotechnology developers to deliver
profitable new medical technologies and innovations. For more
information on our growth-oriented business initiatives, please
visit www.RainbowBioSciences.com. For investment information and
performance data, please visit
www.RainbowBioSciences.com/investors.html.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended, including statements that include the words
“believes,” “expects,” “anticipate” or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the Company to differ materially
from those expressed or implied by such forward-looking statements.
In addition, description of anyone’s past success, either financial
or strategic, is no guarantee of success. This news release speaks
as of the date first set forth above and the Company assumes no
responsibility to update the information included herein for events
occurring after the date hereof.